Belite Bio (BLTE) Retained Earnings (2020 - 2025)

Belite Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at -$185.3 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 72.1% year-over-year to -$185.3 million; the TTM figure through Dec 2025 stood at -$185.3 million (down 72.1% YoY), while the FY2025 annual figure was -$185.3 million, down 72.1% from the prior year.
• Retained Earnings was -$185.3 million for Q4 2025 at Belite Bio, down from -$159.9 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$27.2 million in Q4 2021 to a low of -$185.3 million in Q4 2025.
• Historically, Retained Earnings has averaged -$98.6 million across 5 years, with a median of -$89.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings slumped 46.46% in 2022, then tumbled 79.34% in 2023.
• A 5-year view of Retained Earnings shows it stood at -$27.2 million in 2021, then tumbled by 46.46% to -$39.9 million in 2022, then tumbled by 79.34% to -$71.5 million in 2023, then plunged by 50.55% to -$107.6 million in 2024, then tumbled by 72.1% to -$185.3 million in 2025.
• The last three Retained Earnings figures came in at -$185.3 million (Q4 2025), -$159.9 million (Q3 2025), and -$107.6 million (Q4 2024), per Business Quant data.